期刊文献+

45例中心静脉双腔导管血栓形成尿激酶溶栓治疗的体会 被引量:5

The thrombolytic therapy of Urokinase in 45 patients with central venous double-lumen catheter thrombosis
下载PDF
导出
摘要 目的:探讨中心静脉双腔导管血栓形成治疗的有效办法。方法:45例肾功能衰竭留置中心静脉双腔导管的患者,经确定采用中心静脉导管栓塞后,先用尿激酶10万U+生理盐水10 ml配成浓度为1万U/ml尿激酶溶液,予以1 ml注射器于血栓形成侧导管内缓慢注射尿激酶溶液1.0 ml,10 min后再注射尿激酶溶液0.3~0.5 ml,再过10 min注射尿激酶溶液0.3~0.5 ml,保留10 min后用10 ml注射器抽吸导管,导管通畅即接生理盐水点滴数分钟,若血透导管不通可重复上述步骤。结果:45例采用此法治疗的患者中,43例导管再通,2例因导管栓塞时间大于3 d,溶栓治疗失败,改其他部位重新置管。结论:早期应用此法溶栓治疗导管再通率高,减少患者再次置管的痛苦及经济负担。 Objective: To investigate the effective method of the double-lumen central venous catheter thrombosis.Methods: 45 cases of renal failure,indwelling central venous double-lumen catheter in patients with central venous catheter thrombosis was established,the first with Urokinase 100 000 U+saline 10 ml dubbed concentration 10 000 U/ml Urokinase solution to 1 ml syringe in thrombosis slow side of intraductal injection of Urokinase solution 1.0 ml,10 min after the injection of Urokinase solution of 0.3~0.5 ml,another 10 min injection of Urokinase solution 0.3~0.5 ml,after 10 min with 10 ml syringe to retain suction catheter,immediately following saline drip a few minutes,if the dialysis catheter barrier can repeat these steps.Results: 45 cases of patients treated with this method in 43 cases of ductal patency,catheter embolization in 2 cases because of time greater than 3 days,thrombolytic treatment failure,changed other parts of the re-tube.Conclusion: The early treatment of catheter method has been applied thrombolytic recanalization rate and reduce the suffering of patients with re-catheterization and economic burden.
出处 《中国医药导报》 CAS 2011年第21期132-133,共2页 China Medical Herald
关键词 尿激酶 血液透析 双腔导管 溶栓治疗 Urokinase Hemodialysis Double-lumen catheter Thrombolytic therapy
  • 相关文献

参考文献6

二级参考文献13

共引文献121

同被引文献31

  • 1广东省卫生厅.临床护理技术规范[M].广州:广东科技出版社,2007:30.
  • 2Ogawa A, Mori E, Minematsu K, et al.Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan [J].Stroke, 2007, 38(10):2233-2269.
  • 3Nikolsky E, Mehran R, Yu J, et al.Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI]trial)[J].Am J Cardiol, 2013, 111(10):1377-1386.
  • 4Forti P, Maioli F, Procaccianti G, et al.Independent predictors of ischemic stroke in the elderly: prospective data from a stroke unit[J].Neurology.2013,80(1):29-38.
  • 5Mangiafico S, Cellerini M, Nencini P, et al.Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke[J].Am J Neuroradiol, 2005, 26(10):2595-2601.
  • 6Wang QS, Chen C, Chen XY, et al.Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease[J].Arch Neurol,2012, 69(11):1454-1460.
  • 7Macleod MR, Davis SM, Mitchell PJ, et al.Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke[J].Cerebrovasc Dis,2005,20(1):12.
  • 8Turpie AG, Hull RD, Schellong SM, et al.Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study[J].Stroke, 2013, 44(1):249-251.
  • 9Nikolsky E, McLaurin BT, Cox DA, et al.Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial[J].JACC Cardiovasc Interv, 2012, 5(9):919-926.
  • 10Wang QS, Chen C, Chen XY, et al.Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study [J].Stroke, 2012, 43(2):346-349.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部